US2009004270A1PendingUtilityA1
Method of using guava extract
Est. expiryJan 6, 2026(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/00A61K 36/61A23L 2/52A61P 1/00A61K 9/0058A23L 33/105A23V 2002/00A61K 9/0095A61K 9/0007
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of using guava extract is disclosed that includes administering guava extract to a mammal to inhibit, prevent or alleviate at least one of a headache, nausea, dry mouth, lack of appetite, shakiness, and fatigue. A composition is also disclosed that includes a pharmaceutically acceptable carrier and guava extract.
Claims
exact text as granted — not AI-modified1 . A method of using guava extract, said method comprising administering the guava extract to a human experiencing a headache in an amount sufficient to alleviate the headache.
2 . The method of claim 1 , wherein said administering comprises administering at least 250 mg of guava extract to said mammal.
3 . The method of claim 1 , wherein said administering comprises administering at least 500 mg of guava extract to said mammal.
4 . The method of claim 1 , wherein said administering comprises administering at least about 1000 mg of guava extract to said mammal.
5 . The method of claim 1 , wherein said guava extract comprises a water-soluble extract of guava leaves.
6 . The method of claim 1 , wherein said guava extract comprises at least one of an organic solvent soluble extract of guava leaves and an oil soluble extract of guava leaves.
7 . The method of claim 1 , wherein said administering comprises administering an effervescent tablet comprising the guava extract, an effervescent couple comprising an acid and a base, a binder and a lubricant.
8 . A method of using guava extract, said method comprising administering guava extract to a human within no greater than 24 hours of said human feeling a headache.
9 . The method of claim 8 , wherein said administering guava extract occurs prior to said human feeling a headache.
10 . The method of claim 8 , wherein said administering guava extract occurs within about 1 hour of said human feeling a headache.
11 . The method of claim 8 , wherein said administering guava extract comprises administering at least 250 mg of guava extract.
12 . The method of claim 8 , wherein said administering guava extract comprises administering at least 500 mg of guava extract.
13 . The method of claim 8 , wherein said administering guava extract comprises administering at least about 1000 mg guava extract.
14 . A method of using guava extract, said method comprising administering guava extract to a human in an amount sufficient to prevent a feeling of a headache in the human.
15 . The method of claim 14 , wherein said administering comprises administering at least 250 mg of guava extract to said mammal.
16 . The method of claim 14 , wherein said administering comprises administering at least 500 mg of guava extract to said mammal.
17 . The method of claim 14 , wherein said administering guava extract comprises administering at least about 1000 mg guava extract.
18 . A method of using guava extract, said method comprising administering guava extract to a human at a time sufficient to alleviate a feeling of a headache in the human.
19 . The method of claim 18 , wherein said administering guava extract comprises administering at least about 1000 mg guava extract.
20 . A method of using guava extract, said method comprising administering guava extract to a human who expects to feel a headache.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.